IL155691A0 - Oral pharmaceutical composition containing a block copolymer - Google Patents

Oral pharmaceutical composition containing a block copolymer

Info

Publication number
IL155691A0
IL155691A0 IL15569101A IL15569101A IL155691A0 IL 155691 A0 IL155691 A0 IL 155691A0 IL 15569101 A IL15569101 A IL 15569101A IL 15569101 A IL15569101 A IL 15569101A IL 155691 A0 IL155691 A0 IL 155691A0
Authority
IL
Israel
Prior art keywords
copolymer
oral pharmaceutical
block copolymer
pharmaceutical composition
composition containing
Prior art date
Application number
IL15569101A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0027375A external-priority patent/GB0027375D0/en
Priority claimed from GB0104751A external-priority patent/GB0104751D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL155691A0 publication Critical patent/IL155691A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
IL15569101A 2000-11-09 2001-11-07 Oral pharmaceutical composition containing a block copolymer IL155691A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0027375A GB0027375D0 (en) 2000-11-09 2000-11-09 Pharmaceutical composition
GB0104751A GB0104751D0 (en) 2001-02-27 2001-02-27 Pharmaceutical composition
PCT/SE2001/002470 WO2002038184A1 (en) 2000-11-09 2001-11-07 Oral pharmaceutical composition containing a block copolymer

Publications (1)

Publication Number Publication Date
IL155691A0 true IL155691A0 (en) 2003-11-23

Family

ID=26245262

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15569101A IL155691A0 (en) 2000-11-09 2001-11-07 Oral pharmaceutical composition containing a block copolymer

Country Status (20)

Country Link
US (1) US20040076673A1 (de)
EP (1) EP1343530B1 (de)
JP (1) JP4255692B2 (de)
KR (1) KR20030057549A (de)
CN (1) CN100408099C (de)
AT (1) ATE369151T1 (de)
AU (1) AU2002214466A1 (de)
BR (1) BR0115204A (de)
CA (1) CA2428784A1 (de)
CY (1) CY1106908T1 (de)
DE (1) DE60129838T2 (de)
DK (1) DK1343530T3 (de)
ES (1) ES2289002T3 (de)
HK (1) HK1061646A1 (de)
IL (1) IL155691A0 (de)
MX (1) MXPA03004112A (de)
NO (1) NO20032070L (de)
NZ (1) NZ525726A (de)
PT (1) PT1343530E (de)
WO (1) WO2002038184A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
CN1290893C (zh) * 2002-05-03 2006-12-20 詹森药业有限公司 聚合物微乳状液
KR100502840B1 (ko) 2002-09-04 2005-07-21 학교법인 포항공과대학교 약물 담지능력이 우수한 블록 공중합체 미셀 조성물
US7263401B2 (en) * 2003-05-16 2007-08-28 Medtronic, Inc. Implantable medical device with a nonhermetic battery
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20060224095A1 (en) * 2005-04-05 2006-10-05 University Of New Hampshire Biocompatible polymeric vesicles self assembled from triblock copolymers
KR100665672B1 (ko) * 2005-04-13 2007-01-09 성균관대학교산학협력단 새로운 온도 및 ｐＨ 민감성 블록 공중합체 및 이를 이용한고분자 하이드로겔
DE112006000685B4 (de) * 2005-04-13 2016-03-10 Sungkyunkwan University Foundation For Corporate Collaboration Temperatur- und pH-empfindliches Blockcopolymer und daraus hergestellte Polymerhydrogele
CN100334219C (zh) * 2005-05-12 2007-08-29 华中科技大学同济医学院附属同济医院 共聚物促进超声介导基因转染的方法
DE602007004955D1 (de) * 2006-03-09 2010-04-08 Coloplast As Abbaubare copolymere mit einem hydrophilen block mit verbesserter biokompatibilität für die weichgeweberegeneration
EP2098256B1 (de) * 2006-11-17 2016-06-08 National Cerebral and Cardiovascular Center Bloodgerinnung verhinderndes material, beschichtungsmaterial und durch verwendung des materials hergestellte in-vivo-verweilelemente und behandlungsverfahren
KR100949850B1 (ko) * 2007-11-16 2010-03-29 성균관대학교산학협력단 약물방출성이 우수한 온도 및 피에치 민감성 블록공중합체및 이의 제조방법과 이를 이용한 약물전달체
RU2490009C2 (ru) 2008-02-22 2013-08-20 Торэй Индастриз, Инк. Микрочастица и ее фармацевтическая композиция
CN101732724B (zh) * 2010-01-07 2012-04-25 浙江大学 一种携载抗肿瘤药物的复合胶束及其制备方法
CN101899146B (zh) * 2010-07-28 2012-04-18 重庆大学 一种基于哌嗪嵌段端羟基聚酯类材料及其制备方法
CN101982168B (zh) * 2010-11-02 2012-05-23 山东大学 一种槲皮素纳米胶束制剂及其制备方法
CN102935062B (zh) * 2011-08-16 2014-10-15 王成 负载埃坡霉素类化合物或其衍生物的聚合物胶束组合物、冻干制剂的制备及应用
TWI641396B (zh) 2011-09-23 2018-11-21 Bvw控股公司 醫療共聚物
CU24287B1 (es) * 2012-06-27 2017-12-08 Medincell Suministro de fármaco biodegradable para las composiciones hidrofóbicas
CN103006557A (zh) * 2012-11-29 2013-04-03 中国人民解放军军事医学科学院毒物药物研究所 丝裂霉素a胶束制剂、其制备方法及用途
CA2909864C (en) 2013-04-25 2021-06-15 Charles S. Arena Disassembleable cheese container with wrap-around interlock and increased fill volume
CN105902515B (zh) * 2016-05-19 2019-04-05 宁波盖济尔医疗科技有限公司 纳米药物存储器、其制备方法及其应用
KR102184768B1 (ko) * 2018-12-31 2020-11-30 중앙대학교 산학협력단 혼합 고분자 미셀 조성물 및 이의 용도

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419446A (en) * 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
US4588683A (en) * 1984-02-06 1986-05-13 Eastman Kodak Company Method of preparing 11β, 17α, 20, 21-tetrahydroxy steroids and corresponding 11β, 17α, 21-trihydroxy-20-oxo steroids
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5869283A (en) * 1988-05-06 1999-02-09 Roussel Uclaf Expression cassette operable in a recombinant host
EP0528906B1 (de) * 1990-04-30 1995-10-11 The Board Of Regents, The University Of Texas System Steroid 5-alpha-reduktase
US5384253A (en) * 1990-12-28 1995-01-24 Dekalb Genetics Corporation Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
US5348886A (en) * 1992-09-04 1994-09-20 Monsanto Company Method of producing recombinant eukaryotic viruses in bacteria
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
ES2175175T3 (es) * 1995-12-12 2002-11-16 Akzo Nobel Nv Un metodo microbiano para la 11alfa-hidroxilacion de esteroides.
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
KR20010030891A (ko) * 1997-10-03 2001-04-16 마크로메드 인코퍼레이션 가역적 열 겔화 성질을 갖는 생분해성 저분자량 트리블럭폴리(락티드-코-글리콜리드) 폴리에틸렌 글리콜 공중합체
PT1082321E (pt) * 1998-05-02 2005-03-31 Astrazeneca Ab Derivados heterociclicos que inibem o factor xa
KR100274842B1 (ko) * 1998-10-01 2001-03-02 김효근 미립구를 이용한 레티노익산의 서방형 약물방출 시스템
US6338859B1 (en) * 2000-06-29 2002-01-15 Labopharm Inc. Polymeric micelle compositions

Also Published As

Publication number Publication date
ATE369151T1 (de) 2007-08-15
JP4255692B2 (ja) 2009-04-15
PT1343530E (pt) 2007-09-25
KR20030057549A (ko) 2003-07-04
NO20032070L (no) 2003-07-07
AU2002214466A1 (en) 2002-05-21
WO2002038184A1 (en) 2002-05-16
EP1343530A1 (de) 2003-09-17
CN1474702A (zh) 2004-02-11
DE60129838D1 (de) 2007-09-20
MXPA03004112A (es) 2003-08-19
DE60129838T2 (de) 2008-04-30
BR0115204A (pt) 2004-02-03
CY1106908T1 (el) 2012-09-26
JP2004513154A (ja) 2004-04-30
DK1343530T3 (da) 2007-10-15
ES2289002T3 (es) 2008-02-01
NZ525726A (en) 2004-10-29
US20040076673A1 (en) 2004-04-22
CA2428784A1 (en) 2002-05-16
CN100408099C (zh) 2008-08-06
NO20032070D0 (no) 2003-05-08
EP1343530B1 (de) 2007-08-08
HK1061646A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
IL155691A0 (en) Oral pharmaceutical composition containing a block copolymer
MX2020000618A (es) Composicion farmaceutica.
ATE468848T1 (de) In organischen lösemitteln lösliche biologisch abbaubare poly (alkylenoxid)- poly (p-dioxanon) blockcopolymere sowie diese enthaltende zusammensetzung zur arzneistoffverabreichung
MXPA01007609A (es) Gcsf conjugados.
DK1261320T3 (da) Micellare farmaceutiske sammesætninger til bukkal og pulmonal anvendelse
AR039522A1 (es) Microemulsiones polimericas
ATE418970T1 (de) Pharmazeutische zusammensetzungen - ph-sensitive blockcopolymere und einen hydrophoben wirkstoff enthaltend
NO20016311L (no) Formmasse med god blåseformbarhet
ATE355064T1 (de) Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase
BRPI0514489A (pt) copolìmeros em dibloco biodegradáveis que têm propriedades de gelificação térmica reversa e processos de uso dos mesmos
MXPA02011436A (es) Composiciones farmaceuticas micelares para aplicacion bucal y pulmonar.
CA2135603A1 (en) Solid Dispersion Compositions of Tebufelone
NO2008007I2 (de)
MA27583A1 (fr) Tetrahydro-4h-pyrido [1,2-a] pyrimidines et les composes apparentes utiles comme inhibiteurs de l'integrase du vih.
HRP20031003A2 (en) 4'-substituted nukleosides
JP2005524730A5 (de)
MXPA06014073A (es) Dentifrico antibacterial anti-manchado.
ES2107295T3 (es) Copolimeros de bloques que tienen combinaciones mejoradas de propiedades.
EP1602673A4 (de) Block(co)polymer, blockcopolymerzusammensetzung für die asphaltmodifizierung, herstellungsverfahren dafür und asphaltzusammensetzung
AU2002212894A1 (en) N-type calcium channel antagonists for the treatment of pain
NZ514073A (en) Taxane formulations having improved solubility
WO2002007691A3 (en) Dental compositions
WO2001029066A3 (en) Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
DE60302340D1 (de) Triblock-copolymere für kosmetik- oder pflegezusammensetzungen
MX2023011073A (es) Composicion farmaceutica.